5T89 image
Deposition Date 2016-09-07
Release Date 2017-02-01
Last Version Date 2025-04-09
Entry Detail
PDB ID:
5T89
Keywords:
Title:
Crystal structure of VEGF-A in complex with VEGFR-1 domains D1-6
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
4.00 Å
R-Value Free:
0.31
R-Value Work:
0.28
R-Value Observed:
0.28
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Vascular endothelial growth factor A
Gene (Uniprot):VEGFA
Chain IDs:A (auth: V), B (auth: W)
Chain Length:131
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Vascular endothelial growth factor receptor 1
Gene (Uniprot):FLT1
Chain IDs:C (auth: X), D (auth: Y)
Chain Length:646
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structure of the Full-length VEGFR-1 Extracellular Domain in Complex with VEGF-A.
Structure 25 341 352 (2017)
PMID: 28111021 DOI: 10.1016/j.str.2016.12.012

Abstact

Vascular endothelial growth factors (VEGFs) regulate blood and lymph vessel development upon activation of three receptor tyrosine kinases: VEGFR-1, -2, and -3. Partial structures of VEGFR/VEGF complexes based on single-particle electron microscopy, small-angle X-ray scattering, and X-ray crystallography revealed the location of VEGF binding and domain arrangement of individual receptor subdomains. Here, we describe the structure of the full-length VEGFR-1 extracellular domain in complex with VEGF-A at 4 Å resolution. We combined X-ray crystallography, single-particle electron microscopy, and molecular modeling for structure determination and validation. The structure reveals the molecular details of ligand-induced receptor dimerization, in particular of homotypic receptor interactions in immunoglobulin homology domains 4, 5, and 7. Functional analyses of ligand binding and receptor activation confirm the relevance of these homotypic contacts and identify them as potential therapeutic sites to allosterically inhibit VEGFR-1 activity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures